NZ196883A - Topical anti-inflammatory formulations containing 4-amino-1-beta-d-ribofuranosyl-1h-imidazo(4.5-c)-pyridine - Google Patents

Topical anti-inflammatory formulations containing 4-amino-1-beta-d-ribofuranosyl-1h-imidazo(4.5-c)-pyridine

Info

Publication number
NZ196883A
NZ196883A NZ196883A NZ19688381A NZ196883A NZ 196883 A NZ196883 A NZ 196883A NZ 196883 A NZ196883 A NZ 196883A NZ 19688381 A NZ19688381 A NZ 19688381A NZ 196883 A NZ196883 A NZ 196883A
Authority
NZ
New Zealand
Prior art keywords
formulation
ribofuranosyl
deazaadenosine
amino
inflammation
Prior art date
Application number
NZ196883A
Other languages
English (en)
Inventor
R Vinegar
G Wolberg
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NZ196883A publication Critical patent/NZ196883A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ196883A 1980-04-23 1981-04-22 Topical anti-inflammatory formulations containing 4-amino-1-beta-d-ribofuranosyl-1h-imidazo(4.5-c)-pyridine NZ196883A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8013411A GB2074858B (en) 1980-04-23 1980-04-23 Compositions containing 3-deazaaden-osine

Publications (1)

Publication Number Publication Date
NZ196883A true NZ196883A (en) 1984-07-31

Family

ID=10512973

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ196883A NZ196883A (en) 1980-04-23 1981-04-22 Topical anti-inflammatory formulations containing 4-amino-1-beta-d-ribofuranosyl-1h-imidazo(4.5-c)-pyridine

Country Status (15)

Country Link
EP (1) EP0038567B1 (member.php)
JP (1) JPS56166118A (member.php)
AU (1) AU553680B2 (member.php)
BE (1) BE888525A (member.php)
CA (1) CA1172168A (member.php)
CH (1) CH654316A5 (member.php)
DE (2) DE3116029A1 (member.php)
DK (1) DK179781A (member.php)
GB (1) GB2074858B (member.php)
IE (2) IE51738B1 (member.php)
IL (1) IL62696A (member.php)
IT (1) IT1170910B (member.php)
NL (1) NL8101987A (member.php)
NZ (1) NZ196883A (member.php)
ZA (1) ZA812640B (member.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596637B2 (en) * 1986-08-06 1990-05-10 Sumitomo Chemical Company, Limited Mulching film for repelling insect pests
US4918060A (en) * 1987-09-04 1990-04-17 The Johns Hopkins University Method of treating myasthenia gravis and related diseases
US5137876A (en) * 1990-10-12 1992-08-11 Merck & Co., Inc. Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
ATE335493T1 (de) 1998-09-03 2006-09-15 Kerckhoff Klinik Ges Mit Besch 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie
JP2002274626A (ja) * 2001-03-19 2002-09-25 Okamura Corp ローラコンベヤ装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148888A (en) * 1978-03-13 1979-04-10 The United States Of America As Represented By The Department Of Health, Education And Welfare 3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrolase with antiviral activity
US4309419A (en) * 1978-10-13 1982-01-05 Burroughs Wellcome Co. Method for the inhibition of immune response

Also Published As

Publication number Publication date
IT8148327A1 (it) 1982-10-22
AU553680B2 (en) 1986-07-24
IE51737B1 (en) 1987-03-18
DE3176462D1 (en) 1987-10-29
JPH0428686B2 (member.php) 1992-05-15
IT8148327A0 (it) 1981-04-22
NL8101987A (nl) 1981-11-16
BE888525A (fr) 1981-10-22
JPS56166118A (en) 1981-12-21
IT1170910B (it) 1987-06-03
DE3116029A1 (de) 1982-03-18
IE810891L (en) 1981-10-23
GB2074858A (en) 1981-11-11
AU6971081A (en) 1981-10-29
CA1172168A (en) 1984-08-07
ZA812640B (en) 1982-12-29
EP0038567B1 (en) 1987-09-23
CH654316A5 (de) 1986-02-14
IL62696A (en) 1984-03-30
IL62696A0 (en) 1981-06-29
DE3116029C2 (member.php) 1991-01-17
IE51738B1 (en) 1987-03-18
GB2074858B (en) 1985-03-20
EP0038567A1 (en) 1981-10-28
DK179781A (da) 1981-10-24
IE811594L (en) 1981-10-23

Similar Documents

Publication Publication Date Title
US4322411A (en) Anti-inflammatory nucleosides
US4505896A (en) Method of treating acne vulgaris and composition
RU2238083C2 (ru) Лечение хронической экземы кожи рук
US4088756A (en) Pharmaceutical composition and process of treatment
US4034087A (en) Pharmaceutical composition and process of treatment
US4107306A (en) Process for treating proliferative skin disease
JP2001508429A (ja) 選択プロスタグランジンエンドペルオキシドシンターゼ−２の阻害剤
US5258391A (en) Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use
US4144332A (en) Process for alleviating proliferative skin diseases
AU616755B2 (en) Topically applied gold organic complex
NZ196883A (en) Topical anti-inflammatory formulations containing 4-amino-1-beta-d-ribofuranosyl-1h-imidazo(4.5-c)-pyridine
KR100191191B1 (ko) 인터루킨-8합성억제의 카르보스티릴 유도체
JPH0753359A (ja) リポキシゲナーゼ阻害剤
US4007268A (en) Process for alleviating proliferative skin diseases
US3934018A (en) 4,6-Dihydro-1,3-dimethyl-8-phenylpyrazolo[4,3-e] [1,4]diazepin-5-(1H)-one and derivatives as anti-inflammatory agents
US5726183A (en) Use of quinoline-3-carboxamide compounds
EP1263421B1 (en) The dual inhibitor of cholesteryl ester and wax ester synthesis avasimibe for treating sebaceous gland disorders
US5321045A (en) Method and composition for the treatment of imflammatory conditions using thiosulphinic acid derivatives
EP0228239B1 (en) Preparation of a medicament for arthritis and rheumatism
NZ205587A (en) Composition comprising undecylenic acid for treating herpes simplex i
US4818759A (en) Treatment of disease
JPH08283150A (ja) 抗炎症剤
JPH02210A (ja) ピペリジニルシクロペンチルペンテン酸誘導体を含有する水性処方物
US4481210A (en) Method of treatment
US3790676A (en) Preventing pain,fever and inflammation with cyclic hydroxy sulfoxides